AMGN vs RMTI · P/E 24, rev $10.05B vs rev $35.1M
Amgen Inc (AMGN) versus Rockwell Medical Inc (RMTI) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Rockwell Medical Inc (RMTI) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported RMTI revenue for 2026-06-30 was $35.1M. Net income was -$2.8M. RMTI currently screens at market cap $25.7M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. RMTI currently screens at market cap $25.7M.
Not investment advice. Open the AMGN and RMTI stock pages for the full models.
Not investment advice.